How Radiopharmaceuticals Help Diagnose Cancer and Cardiovascular Disease

6 September 2018

Producer:
Video: Martin Klingenboeck, Story: Alejandra Silva, Additional Footage: Pablo Massip Ginesta

Technetium-99m is the most widely used radioisotope in diagnostic nuclear medicine. Over 10,000 hospitals worldwide use it to detect cancer, cardiovascular and other chronic diseases, so that they can be treated.

Ministerial Conference on Nuclear Science and Technology: Addressing Current and Emerging Development Challenges, 28-30 November
Health
Cancer
Diagnostics
Diagnostic radiopharmaceuticals
Cardiovascular diseases

Department of Nuclear Sciences and Applications Division of Physical and Chemical Sciences Radioisotope Products and Radiation Technology Section Division of Human Health Nuclear Medicine and Diagnostic Imaging Section Cardiovascular diseases Cancer diagnosis Diagnostics Diagnostic radiopharmaceuticals Health Cancer

How Radiopharmaceuticals Help Diagnose Cancer and Cardiovascular Disease

Related Resources

More

More on the IAEA

Scientific resources

Resources

Documents

Stay in Touch